Ilia Voskoboinik

11PUBLICATIONS
46CO-AUTHORS
AutoimmunityMolecular targetsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Photonics, optoelectronics and optical communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2026
Partial STX11 deficiency due to a hypomorphic variant-self-limiting inflammatory disease preceding HLH onset.

|Jan 09, 2025
Acidic pH can attenuate immune killing through inactivation of perforin.

Adrian W Hodel, Jesse A Rudd-Schmidt, Tahereh Noori

|Jan 27, 2023
A cell-based functional assay that accurately links genotype to phenotype in familial HLH.

Tahereh Noori, Jesse A Rudd-Schmidt, Alisa Kane

|Apr 21, 2022
ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack.

Alex T Ritter, Gleb Shtengel, C Shan Xu

|Feb 11, 2022
The pore conformation of lymphocyte perforin.

Marina E Ivanova, Natalya Lukoyanova, Sony Malhotra

|Jan 26, 2022
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1.

Daniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori

Pageof 2

Frequent Collaborators

4 joint publications

Joseph Trapani

4 joint publications

Jesse A Rudd-Schmidt

4 joint publications

Adrian W Hodel

3 joint publications

Tahereh Noori